Skip to main content

Advertisement

Table 2 Prevalence of long-term antipsychotic polypharmacy combinations (nā€‰=ā€‰338)

From: Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process

Antipsychotic medication n Plus at least one other FGAa n (%) Plus at least one other SGAa n (%)
First Generation Antipsychotics (FGA)a
Chlorpromazine 8 1 (12.5) 7 (87.5)
Flupentixol 26 6 (23.1) 20 (76.9)
Fluphenazine 4 2 (50.0) 2 (50.0)
Haloperidol 30 5 (16.7) 25 (83.3)
Levomepromazine 1 - 1 (100.0)
Pericyazine 1 1 (100.0) -
Pimozide 2 - 2 (100.0)
Pipothiazine 10 2 (20.0) 8 (80.0)
Sulpride 33 1 (3.0) 32 (97.0)
Trifluoperazine 3 - 3 (100.0)
Zuclopenthixol 25 - 25 (100.0)
Second Generation Antipsychotics (SGA)a
Amisulpride 118 18 (15.3) 100 (84.7)
Aripiprazole 79 12 (15.2) 67 (84.8)
Clozapine 168 27 (16.1) 141 (83.9)
Olanzapine 95 44 (46.3) 51 (53.7)
Paliperidone 40 8 (20.0) 32 (80.0)
Quetiapine 21 11 (52.4) 10 (47.6)
Risperidone 64 21 (32.8) 43 (67.2)
  1. aThese are overlapping categories; antipsychotic combinations may include additional FGAs or SGA where patients are prescribed more than 2 antipsychotics simultaneously